Account
Inquiry
XCE Tirzepatide is a novel dual GLP-1 and GIP receptor agonist peptide currently under investigation for metabolic applications. This high purity compound (99% by HPLC) is supplied in convenient 10mg vials for research purposes.
The XCE Tirzepatide formulation demonstrates potential effects on glucose regulation and lipid metabolism. Research suggests this peptide may influence weight management through multiple pathways, though all applications require further clinical investigation.
Our facility produces XCE Tirzepatide under strict quality controls to ensure batch-to-batch consistency. The peptide is synthesized using advanced solid-phase peptide synthesis (SPPS) technology followed by rigorous purification processes.
Key characteristics of our XCE Tirzepatide include high biological activity, excellent solubility profile, and stability under recommended storage conditions. The product is supplied as a lyophilized powder in sterile vials with appropriate packaging to maintain integrity during transit.
For research institutions and pharmaceutical developers, we offer custom synthesis services for XCE Tirzepatide derivatives and analogs. Our technical team can assist with specialized modifications including conjugation, labeling, and formulation development.
Note: This product is intended for research purposes only. Not for human consumption or diagnostic use.
